New Key Statistics Module, Z-Score and F-Score
OTCPK:CASBF Key Ratios
| Market Cap $ M | 1,947.31 |
| Enterprise Value $ M | 1,974.86 |
| P/E(ttm) | 209.09 |
| PE Ratio without NRI | 287.50 |
| Forward PE Ratio | 54.76 |
| Price/Book | 1.57 |
| Price/Sales | 11.27 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 96.00 |
| EPS (TTM) $ | 0.02 |
| Beneish M-Score | -2.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 253.28 |
| EV-to-EBITDA | 60.06 |
| PEG | -- |
| Shares Outstanding M | 247.04 |
| Net Margin (%) | 6.02 |
| Operating Margin % | 5.17 |
| Pre-tax Margin (%) | 5.98 |
| Quick Ratio | 3.23 |
| Current Ratio | 3.55 |
| ROA % (ttm) | 0.55 |
| ROE % (ttm) | 0.85 |
| ROIC % (ttm) | 0.78 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.96 |
CASBF Number of Guru Trades
CASBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CASBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CASBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CanSino Biologics Inc Insider Transactions
No Available Data
News about OTCPK:CASBF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers